Legal Opinion

Stahl v. Novartis Pharmaceuticals Corp.

Court of Appeals for the Fifth Circuit

Decided March 18, 2002No. 00-31440PublishedCited by 361 opinions

1Opinion of the Court

KING, Chief Judge:

Plaintiff-Appellant Joseph B. Stahl appeals the district court’s summary judgment in favor of Defendanb-Appellee Novartis Pharmaceuticals Corporation on his claims under the Louisiana Products Liability Act. Stahl also appeals the district court’s prior order dismissing his intentional tort claim. For the following reasons, we AFFIRM.

I. FACTUAL AND PROCEDURAL BACKGROUND

Lamisil is a prescription drug manufactured by Defendanb-Appellee Novartis Pharmaceuticals Corporation (“Novartis”). The drug is approved by the FDA for treatment of fungal infections in the toenails and…

2Cases cited28 opinions

  1. Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
  2. Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
  3. Wallace v. Texas Tech Univ.Court of Appeals for the Fifth Circuit · 1996
  4. Bazley v. TortorichSupreme Court of Louisiana · 1981
  5. White v. Monsanto Co.Supreme Court of Louisiana · 1991

23 more not listed; retrieve them via the Exa API.

3Cited by361 opinions

  1. PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
  2. Thom v. Bristol-Myers Squibb Co.Court of Appeals for the Tenth Circuit · 2003
  3. Michael Wease v. Ocwen Loan Servicing, L.L.C., etCourt of Appeals for the Fifth Circuit · 2019
  4. Gomez v. St. Jude Medical Daig Division Inc.Court of Appeals for the Fifth Circuit · 2006
  5. Weaver v. CCA Industries, Inc.Court of Appeals for the Fifth Circuit · 2008

356 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API